Devicor Medical Products, Inc. part of Leica Biosystems
Devicor Medical Products, Inc. develops medical products and technologies that facilitate minimally invasive medical procedures in the United States and internationally.
Its product portfolio includes Mammotome Breast Biopsy System, neo2000 Gamma Detection System, and tissue markers (MammoMARK, MicroMARK II, and CorMARK) used in breast disease diagnostic sampling and management.
In December 2014, Devicor Medical Products was acquired by Leica Biosystems, part of the Danaher family of companies.
Leica Biosystems is the global leader in anatomic pathology solutions and automation, striving to advance cancer diagnostics to improve patients’ lives.
The combination of the two companies uniquely positions us to develop integrated patient-to-pathology solutions for the diagnosis of cancer.
Headquartered in Cincinnati, Ohio, the Mammotome brand is sold in over 50 different countries throughout the world.
Mammotome remains committed to its heritage of advancing technology for early detection of breast cancer, providing support and education for clinicians worldwide, and offering breast care information for patients.